BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37112678)

  • 1. COVID-19 Vaccine Hesitancy in a Population-Based Study of Minnesota Residents.
    Brandt S; Demmer RT; Walsh S; Mulcahy JF; Zepeda E; Yendell S; Hedberg C; Ulrich AK; Beebe T
    Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey.
    Noh Y; Kim JH; Yoon D; Choe YJ; Choe SA; Jung J; Lee SW; Shin JY
    Epidemiol Health; 2022; 44():e2022061. PubMed ID: 35914771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Vaccine Booster Hesitancy in Malaysia: A Web-Based Cross-Sectional Study.
    Lee KW; Yap SF; Ong HT; Oo M; Swe KMM
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated With the Intention to Receive the COVID-19 Vaccine: Cross-sectional National Study.
    Kasting ML; Macy JT; Grannis SJ; Wiensch AJ; Lavista Ferres JM; Dixon BE
    JMIR Public Health Surveill; 2022 Nov; 8(11):e37203. PubMed ID: 36219842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the Prevalence and Correlates of COVID-19 Booster Vaccine Hesitancy in the Singapore Population Following the Completion of the Primary Vaccination Series.
    Tan KYK; Soh ASE; Ong BWL; Chen MI; Griva K
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study.
    Wu J; Li Q; Silver Tarimo C; Wang M; Gu J; Wei W; Ma M; Zhao L; Mu Z; Miao Y
    Front Immunol; 2021; 12():781161. PubMed ID: 34912346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Booster Uptake: Are Hesitant Adopters Less Likely to Get a Booster Shot Than Nonhesitant Adopters?
    Willis DE; Moore R; Selig JP; CarlLee S; Gurel-Headley MP; Cornett LE; McElfish PA
    Behav Med; 2023 Sep; ():1-9. PubMed ID: 37722699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.
    Luk TT; Lui JHT; Wang MP
    J Med Internet Res; 2022 Oct; 24(10):e39063. PubMed ID: 36179132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Determinants of COVID-19 Vaccine Hesitancy in Nevada.
    Coughenour C; Gakh M; Sharma M; Labus B; Chien LC
    Health Secur; 2021 Nov; 19(6):592-604. PubMed ID: 34882034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults - United States, November-December 2022.
    Lu PJ; Zhou T; Santibanez TA; Jain A; Black CL; Srivastav A; Hung MC; Kriss JL; Schorpp S; Yankey D; Sterrett N; Fast HE; Razzaghi H; Elam-Evans LD; Singleton JA
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(7):190-198. PubMed ID: 36795677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia.
    Wong LP; Alias H; Siaw YL; Muslimin M; Lai LL; Lin Y; Hu Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2078634. PubMed ID: 35648441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
    Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
    JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parental hesitancy towards vaccinating their children with a booster dose against COVID-19: Real-world evidence from Taizhou, China.
    Huang LL; Yang YP; Mao HP; Hu WW; Jiang YH; Jiesisibieke ZL; Tung TH
    J Infect Public Health; 2022 Sep; 15(9):1006-1012. PubMed ID: 35987122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study.
    Roy DN; Azam MS; Islam E
    PLoS One; 2023; 18(4):e0281395. PubMed ID: 37053270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parents' willingness to vaccinate themselves and their children with the booster vaccine against SARS-CoV-2: A cross-sectional study in Puyang city, China.
    Zhou Y; Li GX; Zhao TS; Du J; Zhang WX; Xie MZ; Chen LY; Zeng J; Wang C; Liu B; Liu YQ; Cui F; Lu QB
    J Med Virol; 2023 Jan; 95(1):e28256. PubMed ID: 36305477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine or booster hesitancy among children aged 6 month-5 years, 5-11 years, and 12-17 years in the United States: An analytic cross-sectional study.
    Park C; Vagoyan Zabala P; Irene Trisnadi A
    Prev Med Rep; 2023 Dec; 36():102436. PubMed ID: 37822978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.
    Ehde DM; Roberts MK; Humbert AT; Herring TE; Alschuler KN
    Mult Scler Relat Disord; 2021 Sep; 54():103163. PubMed ID: 34325399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees.
    Attia S; Mausbach K; Klugar M; Howaldt HP; Riad A
    Front Public Health; 2022; 10():846861. PubMed ID: 35462827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.
    Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J
    Front Public Health; 2022; 10():986916. PubMed ID: 36589991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.